Key result
Baseline QRS ≥120 ms was associated with higher crude 1-year mortality, but was not an independent predictor after adjustment.
Why the study?
Does a baseline QRS duration ≥120 ms independently predict one-year mortality, rehospitalization, or their composite in native African adults with chronic heart failure?
Cohort (n=1,047)
Does a baseline QRS duration ≥120 ms independently predict one-year mortality, rehospitalization, or their composite in native African adults with chronic heart failure?
In a large Nigerian chronic heart failure cohort, baseline QRS duration ≥120 ms acts as a marker of a higher-risk clinical and echocardiographic phenotype rather than an independent predictor of 1-year mortality or rehospitalization.
Answers are grounded in this paper and cite their sources.
QRS duration should not independently inform prognosis in chronic HF; leaves open its value within comprehensive risk models.
Prolonged QRS duration reflects ventricular conduction delay and electrical dyssynchrony. It is associated with adverse outcomes in heart failure, but evidence from contemporary African chronic heart-failure cohorts remains limited. To evaluate the relationship between baseline QRS duration and one-year mortality, rehospitalization and the composite of mortality and/or rehospitalization among adults with chronic heart failure in Ibadan, Nigeria. This prospective observational study analyzed data from the Ibadan Heart Failure Project. Adults aged 18 years or older with chronic heart failure, baseline QRS duration, one-year follow-up/vital-status information and valid outcome time were included. QRS duration was analyzed primarily as <120 ms versus ≥120 ms. Mortality was analyzed using Kaplan-Meier curves and Cox proportional-hazards models; rehospitalization and the composite outcome were analyzed using logistic regression. The current analysis was based on participants recruited between 01 January 2016 and 27 June 2023. The final analytic cohort comprised 1047 patients; 380 (36.3%) had QRS ≥120 ms. Patients with prolonged QRS were older, more often male, more likely to have kidney dysfunction and had more adverse echocardiographic remodeling. One-year mortality was higher with QRS ≥120 ms than QRS <120 ms (84/380, 22.1% versus 106/667, 15.9%; log-rank p = 0.012). In univariable Cox analysis, QRS ≥120 ms was associated with mortality (HR 1.44; 95% CI 1.08 to 1.92; p = 0.012). After multivariable adjustment, this association was attenuated (adjusted HR 1.12; 95% CI 0.80 to 1.58; p = 0.504). Adjusted associations with rehospitalization (OR 1.09; 95% CI 0.55 to 2.15; p = 0.813) and the composite outcome (OR 1.19; 95% CI 0.82 to 1.71; p = 0.361) were also non-significant. In this Nigerian chronic heart-failure cohort, QRS ≥120 ms identified a higher-risk clinical phenotype and poorer crude one-year survival. After adjustment, it was not an independent predictor of mortality, rehospitalization or the composite outcome.
No takes yet. Share an insight, caveat, or question.
Orimolade et al. (2026) conducted a cohort in Chronic heart failure (n=1,047). Baseline QRS duration ≥120 ms vs. Baseline QRS duration <120 ms was evaluated on One-year mortality (HR 1.12, 95% CI 0.80-1.58, p=0.504). Baseline QRS ≥120 ms was associated with higher crude 1-year mortality, but was not an independent predictor after adjustment.
Synapse has enriched 10 related papers. Consider them for comparative context: